534 related articles for article (PubMed ID: 33193363)
1. Programmed Cell Death Ligand (PD-L)-1 Contributes to the Regulation of CD4
de Freitas E Silva R; Gálvez RI; Pereira VRA; de Brito MEF; Choy SL; Lotter H; Bosurgi L; Jacobs T
Front Immunol; 2020; 11():574491. PubMed ID: 33193363
[TBL] [Abstract][Full Text] [Related]
2. Immunotherapy using anti-PD-1 and anti-PD-L1 in Leishmania amazonensis-infected BALB/c mice reduce parasite load.
da Fonseca-Martins AM; Ramos TD; Pratti JES; Firmino-Cruz L; Gomes DCO; Soong L; Saraiva EM; de Matos Guedes HL
Sci Rep; 2019 Dec; 9(1):20275. PubMed ID: 31889072
[TBL] [Abstract][Full Text] [Related]
3. TNF contributes to T-cell exhaustion in chronic L. mexicana infections of mice through PD-L1 up-regulation.
González-Tafoya E; Diupotex M; Zamora-Chimal J; Salaiza-Suazo N; Ruiz-Remigio A; Becker I
Cell Immunol; 2020 Dec; 358():104196. PubMed ID: 33032241
[TBL] [Abstract][Full Text] [Related]
4. PD-1 and PD-L1 expression on T-cell subsets in women with unexplained recurrent pregnancy losses.
Wang WJ; Salazar Garcia MD; Deutsch G; Sung N; Yang X; He Q; Jubiz G; Bilal M; Dambaeva S; Gilman-Sachs A; Beaman K; Kwak-Kim J
Am J Reprod Immunol; 2020 May; 83(5):e13230. PubMed ID: 32086851
[TBL] [Abstract][Full Text] [Related]
5. Impairment of the programmed cell death-1 pathway increases atherosclerotic lesion development and inflammation.
Bu DX; Tarrio M; Maganto-Garcia E; Stavrakis G; Tajima G; Lederer J; Jarolim P; Freeman GJ; Sharpe AH; Lichtman AH
Arterioscler Thromb Vasc Biol; 2011 May; 31(5):1100-7. PubMed ID: 21393583
[TBL] [Abstract][Full Text] [Related]
6. Nocardia Rubra Cell Wall Skeleton Up-Regulates T Cell Subsets and Inhibits PD-1/PD-L1 Pathway to Promote Local Immune Status of Patients With High-Risk Human Papillomavirus Infection and Cervical Intraepithelial Neoplasia.
Chen W; Zhang Y; Zhao C; Shao S; Zhang Y; Li X; Bai X; Guo Q; Liu Q; Tang J; Zhang L
Front Immunol; 2020; 11():612547. PubMed ID: 33552075
[TBL] [Abstract][Full Text] [Related]
7.
da Fonseca-Martins AM; de Souza Lima-Gomes P; Antunes MM; de Moura RG; Covre LP; Calôba C; Rocha VG; Pereira RM; Menezes GB; Gomes DCO; Saraiva EM; de Matos Guedes HL
Front Immunol; 2021; 12():598943. PubMed ID: 34211455
[TBL] [Abstract][Full Text] [Related]
8. PD-L1 enhances CNS inflammation and infarct volume following experimental stroke in mice in opposition to PD-1.
Bodhankar S; Chen Y; Vandenbark AA; Murphy SJ; Offner H
J Neuroinflammation; 2013 Sep; 10():111. PubMed ID: 24015822
[TBL] [Abstract][Full Text] [Related]
9. Dual blockade of PD-1 and CTLA-4 combined with tumor vaccine effectively restores T-cell rejection function in tumors.
Duraiswamy J; Kaluza KM; Freeman GJ; Coukos G
Cancer Res; 2013 Jun; 73(12):3591-603. PubMed ID: 23633484
[TBL] [Abstract][Full Text] [Related]
10. CD4+CD25+ regulatory T cells restrain pathogenic responses during Leishmania amazonensis infection.
Ji J; Masterson J; Sun J; Soong L
J Immunol; 2005 Jun; 174(11):7147-53. PubMed ID: 15905558
[TBL] [Abstract][Full Text] [Related]
11. PD-L1 May Mediate T-Cell Exhaustion in a Case of Early Diffuse Leishmaniasis Caused by
Barroso DH; Falcão SAC; da Motta JOC; Sevilha Dos Santos L; Takano GHS; Gomes CM; Favali CBF; de Lima BD; Sampaio RNR
Front Immunol; 2018; 9():1021. PubMed ID: 29867989
[TBL] [Abstract][Full Text] [Related]
12. Immune suppression in premalignant respiratory papillomas: enriched functional CD4+Foxp3+ regulatory T cells and PD-1/PD-L1/L2 expression.
Hatam LJ; Devoti JA; Rosenthal DW; Lam F; Abramson AL; Steinberg BM; Bonagura VR
Clin Cancer Res; 2012 Apr; 18(7):1925-35. PubMed ID: 22322668
[TBL] [Abstract][Full Text] [Related]
13. The PD-1/PD-L1 axis contributes to T-cell dysfunction in chronic lymphocytic leukemia.
Brusa D; Serra S; Coscia M; Rossi D; D'Arena G; Laurenti L; Jaksic O; Fedele G; Inghirami G; Gaidano G; Malavasi F; Deaglio S
Haematologica; 2013 Jun; 98(6):953-63. PubMed ID: 23300177
[TBL] [Abstract][Full Text] [Related]
14. CD4(+) T cells defined by their Vβ T cell receptor expression are associated with immunoregulatory profiles and lesion size in human leishmaniasis.
Keesen TS; Antonelli LR; Faria DR; Guimarães LH; Bacellar O; Carvalho EM; Dutra WO; Gollob KJ
Clin Exp Immunol; 2011 Sep; 165(3):338-51. PubMed ID: 21726211
[TBL] [Abstract][Full Text] [Related]
15. PD-1 modulating Mycobacterium tuberculosis-specific polarized effector memory T cells response in tuberculosis pleurisy.
Li J; Jin C; Wu C; Huang J
J Leukoc Biol; 2019 Sep; 106(3):733-747. PubMed ID: 30861206
[TBL] [Abstract][Full Text] [Related]
16. Human Endothelial Cells Modulate CD4
Lim WC; Olding M; Healy E; Millar TM
Front Immunol; 2018; 9():565. PubMed ID: 29628925
[TBL] [Abstract][Full Text] [Related]
17. Immune evasion via PD-1/PD-L1 on NK cells and monocyte/macrophages is more prominent in Hodgkin lymphoma than DLBCL.
Vari F; Arpon D; Keane C; Hertzberg MS; Talaulikar D; Jain S; Cui Q; Han E; Tobin J; Bird R; Cross D; Hernandez A; Gould C; Birch S; Gandhi MK
Blood; 2018 Apr; 131(16):1809-1819. PubMed ID: 29449276
[TBL] [Abstract][Full Text] [Related]
18. Human CD8
Machicote A; Belén S; Baz P; Billordo LA; Fainboim L
Front Immunol; 2018; 9():2788. PubMed ID: 30555473
[TBL] [Abstract][Full Text] [Related]
19. The early IL-4 response to Leishmania major and the resulting Th2 cell maturation steering progressive disease in BALB/c mice are subject to the control of regulatory CD4+CD25+ T cells.
Aseffa A; Gumy A; Launois P; MacDonald HR; Louis JA; Tacchini-Cottier F
J Immunol; 2002 Sep; 169(6):3232-41. PubMed ID: 12218142
[TBL] [Abstract][Full Text] [Related]
20. Blockade of programmed death-1 ligands on dendritic cells enhances T cell activation and cytokine production.
Brown JA; Dorfman DM; Ma FR; Sullivan EL; Munoz O; Wood CR; Greenfield EA; Freeman GJ
J Immunol; 2003 Feb; 170(3):1257-66. PubMed ID: 12538684
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
